| Literature DB >> 27187352 |
Elixabet Díaz-de-Cerio1,2, Vito Verardo3, Ana María Gómez-Caravaca4,5, Alberto Fernández-Gutiérrez6,7, Antonio Segura-Carretero8,9.
Abstract
Psidium guajava L. is widely used like food and in folk medicine all around the world. Many studies have demonstrated that guava leaves have anti-hyperglycemic and anti-hyperlipidemic activities, among others, and that these activities belong mainly to phenolic compounds, although it is known that phenolic composition in guava tree varies throughout seasonal changes. Andalusia is one of the regions in Europe where guava is grown, thus, the aim of this work was to study the phenolic compounds present in Andalusian guava leaves at different oxidation states (low, medium, and high). The phenolic compounds in guava leaves were determined by HPLC-DAD-ESI-QTOF-MS. The results obtained by chromatographic analysis reported that guava leaves with low degree of oxidation had a higher content of flavonols, gallic, and ellagic derivatives compared to the other two guava leaf samples. Contrary, high oxidation state guava leaves reported the highest content of cyanidin-glucoside that was 2.6 and 15 times higher than guava leaves with medium and low oxidation state, respectively. The QTOF platform permitted the determination of several phenolic compounds with anti-diabetic properties and provided new information about guava leaf phenolic composition that could be useful for nutraceutical production.Entities:
Keywords: HPLC-DAD-ESI-QTOF-MS; Psidium guajava L.; cyanidin-glucoside; flavonols; gallic and ellagic derivatives; phenolic compounds
Mesh:
Substances:
Year: 2016 PMID: 27187352 PMCID: PMC4881523 DOI: 10.3390/ijms17050699
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Quantification (mean ± standard deviation (SD), n = 3) by HPLC-DAD-ESI-QTOF-MS in negative and positive mode of individual compound tentatively identified in P. guajava leaves for the different oxidative states.
| No. | Compound | High | Medium | Low |
|---|---|---|---|---|
| Concentration (μg compound/g leaf | ||||
| 1 | HHDP glucose Isomer | 526 ± 2 c | 651 ± 19 b | 936 ± 10 a |
| 2 | HHDP glucose Isomer | 505 ± 3 c | 645 ± 3 b | 823 ± 16 a |
| 3 | HHDP glucose Isomer | 510 ± 11 c | 645 ± 20 b | 934 ± 2 a |
| 4 | Prodelphinidin B Isomer | 447.1 ± 0.1 c | 515.7 ± 0.4 b | 715 ± 13 a |
| 5 | Gallic acid | 153.52 ± 0.09 c | 164 ± 3 b | 175.9 ± 0.7 a |
| 6 | Pedunculagin/Casuariin Isomer | 158.8 ± 0.6 b | 163.84 ± 0.06 b | 175 ± 3 a |
| 7 | Pedunculagin/Casuariin Isomer | 464.0 ± 0.8 c | 475.5 ± 0.5 b | 557 ± 2 a |
| 8 | Prodelphinidin Dimer Isomer | 497 ± 1 b | 529 ± 6 b | 603 ± 30 a |
| 9 | Gallocatechin | 4913 ± 47 a | 4435 ± 7 b | 4098 ± 84 c |
| 10 | Vescalagin/castalagin Isomer | 157.59 ± 0.01 a | 136.6 ± 0.3 c | 143 ± 2 b |
| 11 | Prodelphinidin Dimer Isomer | 1365 ± 7 c | 1560 ± 14 b | 1739 ± 25 a |
| 12 | Uralenneoside | 2464 ± 4 a | 1911 ± 24 b | 1872 ± 81 b |
| 13 | Geraniin Isomer | 241 ± 1 b | 264.9 ± 0.5 b | 343 ± 25 a |
| 14 | Pedunculagin/Casuariin Isomer | 466 ± 3 c | 575 ± 16 b | 683 ± 20 a |
| 15 | Geraniin Isomer | 260 ± 3 b | 290 ± 7 a,b | 356 ± 48 a |
| 16 | Procyanidin B Isomer | 4262 ± 12 c | 4742 ± 15 b | 5514 ± 69 a |
| 17 | Galloyl(epi)catechin-(epi)gallocatechin | <LOQ | 12.60 ± 0.07 b | 38 ± 3 a |
| 18 | Procyanidin B Isomer | 650 ± 3 c | 708 ± 11 b | 757 ± 23 a |
| 19 | Tellimagrandin I Isomer | 347 ± 4 c | 367.2 ± 0.7 b | 397 ± 2 a |
| 20 | Pterocarinin A Isomer | 569 ± 31 b | 617 ± 9 b | 679 ± 7 a |
| 21 | Pterocarinin A Isomer | 316 ± 2 c | 360 ± 4 b | 376 ± 4 a |
| 22 | Stenophyllanin A | 853 ± 13 c | 1036 ± 50 b | 1318 ± 24 a |
| 23 | Procyanidin trimer Isomer | 781 ± 1 a | 706 ± 1 c | 738 ± 4 b |
| 24 | Catechin | 8486 ± 10 b | 8957 ± 11 a | 6845 ± 24 c |
| 25 | Procyanidin tetramer | <LOQ | <LOQ | <LOQ |
| 26 | Procyanidin trimer Isomer | 89 ± 2 c | 108 ± 3 b | 128 ± 1 a |
| 27 | Guavin A | 263 ± 9 c | 357 ± 8 b | 518 ± 15 a |
| 28 | Casuarinin/Casuarictin Isomer | 1297 ± 5 c | 1568 ± 10 b | 2089 ± 11 a |
| 29 | Galloyl(epi)catechin-(epi)gallocatechin | 61 ± 5 c | 135 ± 1 b | 211 ± 12 a |
| 30 | Procyanidin pentamer | <LOQ | <LOQ | <LOQ |
| 31 | Galloyl-(epi)catechin trimer Isomer | <LOQ | <LOQ | <LOQ |
| 32 | Gallocatechin | 2074 ± 2 b | 1526 ± 2 c | 2613 ± 55 a |
| 33 | Tellimagrandin I Isomer | 463 ± 2 c | 516 ± 6 b | 737 ± 24 a |
| 34 | Vescalagin | 160 ± 6 b | 159 ± 3 b | 187 ± 1 a |
| 35 | Stenophyllanin A Isomer | 355.36 ± 0.07 c | 425 ± 13 b | 548 ± 20 a |
| 36 | Galloyl-(epi)catechin trimer Isomer | <LOQ | <LOQ | <LOQ |
| 37 | Myricetin hexoside Isomer | 432.10 ± 0.05 c | 555 ± 2 b | 572 ± 7 a |
| 38 | Stachyuranin A | 207.40 ± 0.04 a | 207 ± 6 a | 216 ± 1 a |
| 39 | Procyanidin gallate Isomer | 533.2 ± 0.07 c | 799 ± 3 b | 1036 ± 32 a |
| 40 | Myricetin hexoside Isomer | 213 ± 2 c | 288 ± 2 b | 307.8 ± 0.8 a |
| 41 | Vescalagin/castalagin Isomer | 152 ± 3 b | 155 ± 2 b | 191 ± 3 a |
| 42 | Myricetin arabinoside/xylopyranoside Isomer | 241 ± 5 c | 286 ± 2 b | 306 ± 5 a |
| 43 | Myricetin arabinoside/xylopyranoside Isomer | 608 ± 1 c | 839 ± 8 b | 946 ± 11 a |
| 44 | Procyanidin gallate Isomer | 11 ± 1 a | 3.7 ± 0.2 b | <LOQ |
| 45 | Myricetin arabinoside/xylopyranoside Isomer | 688 ± 16 c | 816.0 ± 0.5 b | 874 ± 9 a |
| 46 | Myricetin hexoside Isomer | 1186 ± 13 a | 1010 ± 3 b | 1012 ± 65 b |
| 47 | Myricetin hexoside Isomer | 200 ± 3 b | 208 ± 5 b | 224 ± 6 a |
| 48 | Myricetin arabinoside/xylopyranoside Isomer | 276.0 ± 0.9 a,b | 266 ± 3 b | 282 ± 8 a |
| 49 | Quercetin galloylhexoside Isomer | 375.0 ± 0.6 b | 380 ± 5 b | 438 ± 18 a |
| 50 | Ellagic acid deoxyhexoside | 700 ± 1 a | 702 ± 12 a | 733 ± 32 a |
| 51 | Quercetin galloylhexoside Isomer | 180 ± 2 b | 194 ± 7 a | 205 ± 1 a |
| 52 | Myricetin arabinoside/xylopyranoside Isomer | 544.3 ± 0.4 b | 525 ± 2 b | 588 ± 18 a |
| 53 | Morin | 2619 ± 4 c | 3206 ± 11 b | 4474 ± 98 a |
| 54 | Myricetin arabinoside/xylopyranoside Isomer | 611 ± 4 a | 581 ± 6 b | 559 ± 3 c |
| 55 | Ellagic acid | 1229 ± 26 c | 1345 ± 34 b | 1759.6 ± 0.9 a |
| 56 | Hyperin | 11305 ± 27 c | 11906 ± 57 b | 12528 ± 83 a |
| 57 | Quercetin glucuronide | <LOQ | <LOQ | <LOQ |
| 58 | Isoquercitrin | 2254 ± 10 b | 2471 ± 16 b | 3410 ± 38 a |
| 59 | Procyanidin gallate Isomer | <LOQ | 7.3 ± 0.3 b | 73.3 ± 0.2 a |
| 60 | Reynoutrin | 2641 ± 11 b | 2762 ± 2 b | 3210 ± 104 a |
| 61 | Guajaverin | 8864 ± 8 b | 9668 ± 64 b | 11813 ± 64 a |
| 62 | Guavinoside A | 783 ± 5 a,b | 770 ± 4 b | 793 ± 4 a |
| 63 | Avicularin | 10353 ± 18 a,b | 10173 ± 54 b | 11441 ± 63 a |
| 64 | Quercitrin | 213 ± 2 b | 208 ± 2 b | 223 ± 1 a |
| 65 | Myrciaphenone B | 546 ± 6 c | 621 ± 1 b | 715 ± 20 a |
| 66 | Guavinoside C | 2069 ± 1 b | 1966 ± 21 c | 2209 ± 21 a |
| 67 | Guavinoside B | 872 ± 17 c | 1035 ± 23 b | 1273 ± 30 a |
| 68 | Guavinoside A Isomer | 137 ± 1 a | 135.1 ± 0.6 a | 137 ± 3 a |
| 69 | Guavinoside B Isomer | 120 ± 2 b | 119,6 ± 0.2 b | 129 ± 1 a |
| 70 | 2,6-dihydroxy-3-methyl-4- | 1179 ± 12 b | 1242 ± 33 b | 1365 ± 20 a |
| 71 | Guavin B | 220.51 ± 0.03 b | 230.1 ± 0.7 a,b | 241 ± 7 a |
| 72 | Quercetin | 258 ± 4 a | 253 ± 3 a | 255 ± 5 a |
| 73 | Naringenin | 487 ± 3 c | 638 ± 24 b | 705 ± 6 a |
| Concentration (μg compound/g leaf | ||||
| 74 | Cyanidin-3- | 441.28 ± 0.04 a | 169.3 ± 0.5 b | 29.5 ± 0.2 c |
LOQ: limits of quantification; means in the same line with different letter (a,b,c) are significantly different (p < 0.05).
Figure 1Fragmentation pattern of cyanidin-3-O-glucoside. MS/MS spectra has been obtained by auto MS/MS fragmentation.
Figure 2Quantification of different families of phenolic compounds present in guava leaves at different oxidative states. The different letter (a,b,c) in the same phenolic class means a significant difference (p ≤ 0.05).
Guava leaves’ bioactive compounds related with anti-diabetic properties.
| Compound | Assay | Activity | Ref. |
|---|---|---|---|
| Myrciaphenone B | Inhibition of aldose reductase α-glucosidase | [ | |
| Casuarictin, tellimagrandin I | Inhibition of α-glucosidase | [ | |
| Cyanidin-3- | Inhibition of α-amylase | [ | |
| Flavonol glycosides | Inhibition of dipeptidyl-peptidase IV, and α-glucosidase and α-amylase | [ | |
| Geraniin | Hypoglycemic activity; inhibition of carbohydrate-hydrolysing enzymes (α-glucosidase and α-amylase); effective in preventing advanced glycation end-products (AGEs) formation | [ | |
| Vescalagin | Retard AGEs formation | [ | |
| Gallic acid | Inhibitory effect on the formation of α-dicarbonyl compounds and protein glycation: inhibitory effects on the production of Amadori products and AGEs | [ | |
| Naringenin | Anti-glycation activity | [ | |
| Morin | Protective activity against glycation | [ | |
| Quercetin | Inhibitory effect on protein glycation, on the formation of α-dicarbonyl compounds, and on the production of Amadori products and AGEs | [ | |
| Catechin | Inhibitory effect on the formation of α-dicarbonyl compounds and protein glycation: inhibitory effects on the production of Amadori products and AGEs; improvement of postprandial hyperglycaemia | [ | |
| Procyanidin B2 | Inhibitory effects on the formation of AGEs | [ | |
| Casuarinin, casuariin | Inhibition of insulin-like glucose uptake | [ | |
| Procyanidin oligomers | Insulinomimetic properties | [ | |
| Pedunculagin | Improvement sensitivity of insulin | [ | |
| Gallocatechin | Improvement of postprandial hyperglycaemia | [ |
Comparison (mean ± SD, n = 3) among total phenolic content (TPC) by HPLC-DAD-ESI-QTOF-MS, Trolox Equivalent Antioxidant Capacity (TEAC) and Ferric Reducing Antioxidant Power (FRAP) of Psidium guajava L. leaves at different oxidative states.
| Oxidation State | TPC (mg/g leaf | TEAC (mM eq Trolox/mg leaf | FRAP (mM FeSO4/mg leaf |
|---|---|---|---|
| High | 87.91 ± 0.05 c | 2.2 ± 0.2 c | 3.69 ± 0.03 c |
| Medium | 92.0 ± 0.4 b | 2.44 ± 0.05 b | 4.20 ± 0.06 b |
| Low | 103 ± 2 a | 3.1 ± 0.1 a | 5.4 ± 0.1 a |
Means in the same column with different letter (a,b,c) are significantly different (p < 0.05).